Effectiveness and Safety of Tuberculin Purified Protein Derivative for the Treatment of Anogenital Warts in Patients With Human Immunodeficiency Virus. Dermatol Reports 2024, 16 (3). https://doi.org/10.4081/dr.2024.9754.